Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
Real-time Estimate Tradegate  -  06:03 2022-09-30 am EDT
49.59 EUR   +0.55%
09/21GERRESHEIMER AG : JP Morgan remains Neutral
MD
09/19Gerresheimer : Andrea Abt
PU
09/19Dd : Gerresheimer AG : Notification and public disclosure of transactions by persons
EQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
47.5(c) 48(c) 49.32(c) 49.32(c) 49.6 Last
57 352 121 990 104 935 69 968 11 709 Volume
+0.38% +1.05% +2.75% 0.00% +0.57% Change
More quotes
Estimated financial data (e)
Sales 2022 1 721 M 1 681 M 1 681 M
Net income 2022 106 M 103 M 103 M
Net Debt 2022 1 078 M 1 053 M 1 053 M
P/E ratio 2022 14,6x
Yield 2022 2,68%
Sales 2023 1 850 M 1 807 M 1 807 M
Net income 2023 146 M 143 M 143 M
Net Debt 2023 1 053 M 1 028 M 1 028 M
P/E ratio 2023 10,7x
Yield 2023 3,07%
Capitalization 1 549 M 1 513 M 1 513 M
EV / Sales 2022 1,53x
EV / Sales 2023 1,41x
Nbr of Employees 10 803
Free-Float 100%
More Financials
Company
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of... 
More about the company
Ratings of Gerresheimer AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about GERRESHEIMER AG
09/21GERRESHEIMER AG : JP Morgan remains Neutral
MD
09/19Gerresheimer : Andrea Abt
PU
09/19Dd : Gerresheimer AG : Notification and public disclosure of transactions by persons
EQ
09/07Stevanato, Gerresheimer Develop Ready-to-Use Vial Solution
MT
09/07Gerresheimer AG and Stevanato Group Announces Collaboration on the Development of an In..
CI
09/07Gerresheimer Ag : Gerresheimer AG and Stevanato Group announce Collaboration on the Develo..
EQ
08/19GERRESHEIMER AG : JP Morgan sticks Neutral
MD
08/17Gerresheimer Ag : Gerresheimer and Zollner enter into a strategic partnership for electron..
EQ
08/17Gerresheimer and Zollner Enter into A Strategic Partnership for Electronically Controll..
CI
08/10GERRESHEIMER AG : Buy rating from Deutsche Bank
MD
08/09Gerresheimer : invests up to 94 million Dollar in US production facility
PU
08/09Gerresheimer Ag : Gerresheimer invests up to 94 million Dollar in US production facility
EQ
08/09Gerresheimer Invests Up to $94 Million in US Production Facility
CI
07/26Gerresheimer : focuses on sustainable glass production
PU
07/18Gerresheimer Ag : Notification and public disclosure of transactions by persons
EQ
More news
News in other languages on GERRESHEIMER AG
12:05aWOCHENVORSCHAU: Termine bis 13. Oktober 2022
09/29WOCHENVORSCHAU: Termine bis 12. Oktober 2022
09/19Dd : Gerresheimer AG deutsch
09/19Gerresheimer AG
09/07Gerresheimer AG et le groupe Stevanato annoncent leur collaboration pour le développeme..
More news
Analyst Recommendations on GERRESHEIMER AG
More recommendations
ETFs positioned on GERRESHEIMER AGETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Deka DAXplus Maximum Dividend - EUR2.83%-7.24%Germany
Lyxor S&P Eurozone ESG Dividend Aristocrats...1.44%-3.90%-NC
SPDR S&P Euro Dividend Aristocrats - EUR1.43%-4.38%Europe
Invesco MDAX Acc - EUR1.21%-6.24%Germany
IShares MDAX (DE) - EUR1.18%-6.24%Germany
More ETFs positioned on GERRESHEIMER AG
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 49,32 €
Average target price 88,69 €
Spread / Average Target 79,8%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG-41.77%1 513
ABBOTT LABORATORIES-30.16%172 880
MEDTRONIC PLC-20.47%109 775
BECTON, DICKINSON AND COMPANY-7.99%65 700
HOYA CORPORATION-19.61%34 187
DEXCOM, INC.-38.84%32 714